首页|LDL-C/HDL-C对急性非ST段抬高型急性心肌梗死患者介入治疗预后的预测价值

LDL-C/HDL-C对急性非ST段抬高型急性心肌梗死患者介入治疗预后的预测价值

扫码查看
目的 探讨低密度脂蛋白胆固醇(LDL-C)/高密度脂蛋白胆固醇(HDL-C)对急性非ST段抬高型急性心肌梗死(NSTEMI)患者介入治疗预后的预测价值.方法 选择医院2021年6月至2022年6月收治的105例接受经皮冠状动脉介入治疗的NSTEMI患者为研究对象,所有患者入院时记录一般资料,采集血液标本,检测血清LDL-C、HDL-C水平,并计算LDL-C/HDL-C值.介入治疗后均进行为期1 a的随访,观察患者预后情况,采用logistic回归分析NSTEMI患者介入治疗预后的危险因素,并绘制受试者工作特征(ROC)曲线,检验LDL-C/HDL-C对NSTEMI患者介入治疗预后的预测价值.结果 105例NSTEMI患者介入治疗出院后被随访1 a,25例(23.81%)发生主要心血管不良事件,纳入预后不良组,80例未发生主要心血管不良事件,纳入预后良好组.预后不良组血清cTnT、LDL-C、LDL-C/HDL-C水平均高于预后良好组,HDL-C水平低于预后良好组(P<0.05);经logistic回归分析,cTnT、LDL-C、LDL-C/HDL-C是NSTEMI患者介入治疗预后不良的危险因素(OR>1,P<0.05),HDL-C是NSTEMI患者介入治疗预后不良的保护因素(OR<1,P<0.05).LDL-C、HDL-C、LDL-C/HDL-C预测NSTEMI患者介入治疗预后情况的曲线下面积(AUC)分别为0.677、0.795、0.808.结论 LDL-C/HDL-C与NSTEMI患者介入治疗预后情况密切相关,其水平上调可提示介入治疗预后不良发生风险增加.
Predictive Value of LDL-C/HDL-C for the Prognosis of Interventional Therapy in Patients with Acute Non-ST-Segment Elevation Myocardial Infarction
Objective To explore the predictive value of low-density lipoprotein cholesterol(LDL-C)/high-density lipoprotein cholesterol(HDL-C)on the prognosis of interventional therapy in patients with acute non-ST-segment elevation myocardial infarction(NSTEMI).Methods A total of 105 NSTEMI patients admitted to the hospital from June 2021 to June 2022 who underwent percutaneous coronary intervention were selected as the study subjects.Baseline data were recorded at admission,blood samples were collected,serum LDL-C and HDL-C levels were measured,and the LDL-C/HDL-C ratio was calculated.After intervention therapy,a one-year follow-up was conducted to observe the prognosis of patients.Logistic regression analysis was used to analyze the risk factors for intervention therapy prognosis in NSTEMI patients,and receiver operating characteristic(ROC)curves were drawn to test the predictive value of LDL-C/HDL-C for intervention therapy prognosis in NSTEMI patients.Results A total of 105 NSTEMI patients were followed up for 1 year after discharge after interventional treatment.There were 25 patients(23.81%)with major adverse cardiovascular events were classified as the poor prognosis group,and 80 patients without major adverse cardiovascular events were classified as the good prognosis group.The serum levels of cTnT,LDL-C,LDL-C and HDL-C in the poor prognosis group were higher than those in the good prognosis group,while the HDL-C level was lower than that in the good prognosis group(P<0.05).Logistic regression analysis showed that cTnT,LDL-C,LDL-C/HDL-C were risk factors for poor prognosis after intervention in NSTEMI patients(OR>1,P<0.05),while HDL-C was a protective factor for poor prognosis after intervention in NSTEMI patients(OR<1,P<0.05).The area under the curve(AUC)of LDL-C,HDL-C and LDL-C/HDL-C predicting the prognosis of NSTEMI patients after interventional treatment were 0.677,0.795 and 0.808,respectively.Conclusion LDL-C/HDL-C is closely related to the prognosis of NSTEMI patients undergoing interventional therapy,the upregulation of its level can indicate an increased risk of poor prognosis after interventional therapy.

acute non-ST-segment elevation myocardial infarctionlow-density lipoprotein cholesterolhigh-density lipoprotein cholesterolinterventional therapyprognosis

宋春阳、葛文坤、王勇

展开 >

商丘市立医院心血管内科,河南商丘 476000

商丘市第一人民医院心内一科,河南商丘 476000

急性非ST段抬高型急性心肌梗死 低密度脂蛋白胆固醇 高密度脂蛋白胆固醇 介入治疗 预后

2024

河南医学研究
河南省医学科学院

河南医学研究

影响因子:0.979
ISSN:1004-437X
年,卷(期):2024.33(10)
  • 15